open access

Vol 11, No 1 (2005)
Research paper
Published online: 2005-01-14
Get Citation

The role of red blood cells in adaptation to exercise of patients with atherosclerotic ischemia of lower limbs

Włodzimierz Drożdż, Władysław Lejman, Mariusz Wilczek, Kinga Gajdzińska
Acta Angiologica 2005;11(1):24-37.

open access

Vol 11, No 1 (2005)
Original papers
Published online: 2005-01-14

Abstract

Background. The effects of treatment conducted on patients suffering from atherosclerosis and ischemia of lower limbs on red cells: elasticity, erythropoesis, oxygen dissociability from hemoglobin, and antioxidative potential was investigated
Material and methods. Sixty three patients with mean claudication distance of 400 m and AB/I 0.70 undergoing conservative treatment (12 weeks of controlled treadmill training and pentoxifylline administration), and forty four patients with critical leg ischemia mean claudication distance below 50 m or rest pain, AB/I 0.30 who underwent surgical revascularisation (bypass grafts) were included in the present study. The controls consisted of 22 age-matched patients without signs of leg ischemia. Blood samples for evaluation of red cell deformability, concentration of diphosphoglyceric acid (2,3-DPG), reticulocyte count and red cell antioxidant status: concentration of reduced gluthation (GSH), and superoxide dysmutase (SOD) [EC-1.15.1.1] were collected at entry, after 6 weeks and after 12 weeks from initiation of the treatment or after operation. The changes in clinical status were expressed by claudication appearing time (CAT), maximal walking time (MWT) and ankle/brachial index (ABI) values.
Results. In both groups of patients, after 12 weeks there were signs of significant clinical symptomatic improvement expressed as prolongation of CAT and MWT. In the group subjected to conservative treatment, after 12 weeks there was a significant increase of red cell deformability, enhanced erythroneocytosis, oxygen dissociation from haemoglobin (increased 2,3-DPG concentration), and increased red cell antioxidant potential measured by the GSH and SOD concentrations.
Conversely, in the group subjected to successful surgical revascularisation, in spite of significant clinical improvement 12 weeks after operation, both the low red cell deformability and antioxidant potential were not normalized.
Conclusions. In the case of patients with moderate atheromatous leg ischemia subjected to conservative treatment, red cells play an active part in the development of adaptive mechanisms to physical effort. This effect was not observed in the group of patients with critical leg ischemia after revascularisation.

Abstract

Background. The effects of treatment conducted on patients suffering from atherosclerosis and ischemia of lower limbs on red cells: elasticity, erythropoesis, oxygen dissociability from hemoglobin, and antioxidative potential was investigated
Material and methods. Sixty three patients with mean claudication distance of 400 m and AB/I 0.70 undergoing conservative treatment (12 weeks of controlled treadmill training and pentoxifylline administration), and forty four patients with critical leg ischemia mean claudication distance below 50 m or rest pain, AB/I 0.30 who underwent surgical revascularisation (bypass grafts) were included in the present study. The controls consisted of 22 age-matched patients without signs of leg ischemia. Blood samples for evaluation of red cell deformability, concentration of diphosphoglyceric acid (2,3-DPG), reticulocyte count and red cell antioxidant status: concentration of reduced gluthation (GSH), and superoxide dysmutase (SOD) [EC-1.15.1.1] were collected at entry, after 6 weeks and after 12 weeks from initiation of the treatment or after operation. The changes in clinical status were expressed by claudication appearing time (CAT), maximal walking time (MWT) and ankle/brachial index (ABI) values.
Results. In both groups of patients, after 12 weeks there were signs of significant clinical symptomatic improvement expressed as prolongation of CAT and MWT. In the group subjected to conservative treatment, after 12 weeks there was a significant increase of red cell deformability, enhanced erythroneocytosis, oxygen dissociation from haemoglobin (increased 2,3-DPG concentration), and increased red cell antioxidant potential measured by the GSH and SOD concentrations.
Conversely, in the group subjected to successful surgical revascularisation, in spite of significant clinical improvement 12 weeks after operation, both the low red cell deformability and antioxidant potential were not normalized.
Conclusions. In the case of patients with moderate atheromatous leg ischemia subjected to conservative treatment, red cells play an active part in the development of adaptive mechanisms to physical effort. This effect was not observed in the group of patients with critical leg ischemia after revascularisation.
Get Citation

Keywords

atherosclerosis; ischemia of the legs; red cells; deformability; antioxidant potential

About this article
Title

The role of red blood cells in adaptation to exercise of patients with atherosclerotic ischemia of lower limbs

Journal

Acta Angiologica

Issue

Vol 11, No 1 (2005)

Article type

Research paper

Pages

24-37

Published online

2005-01-14

Page views

718

Article views/downloads

1711

Bibliographic record

Acta Angiologica 2005;11(1):24-37.

Keywords

atherosclerosis
ischemia of the legs
red cells
deformability
antioxidant potential

Authors

Włodzimierz Drożdż
Władysław Lejman
Mariusz Wilczek
Kinga Gajdzińska

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl